CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.91 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.91 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹3.89 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.91 Cr | -72.67 | |
| Mar2024 | ₹14 Cr | 0.00 | |
| Mar2023 | ₹14 Cr | 7.43 | |
| Mar2022 | ₹13 Cr | 242.57 | |
| Mar2021 | ₹3.89 Cr | - | |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹12,577.1 Cr | -3.6% | 3.3% | -24.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,777.0 Cr | -0.1% | 4.7% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,931.0 Cr | -1.7% | 2.5% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,330.0 Cr | -1.1% | 7.6% | 45.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,593.0 Cr | -0.4% | 6.3% | 14.7% | Stock Analytics | |
| CIPLA | ₹107,112.0 Cr | -2.3% | 0.3% | -8.9% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -3.6% |
3.3% |
-24.2% |
| SENSEX | -2.8% |
-2% |
7.3% |
You may also like the below Video Courses